Needs-based considerations for the role of low-dose aspirin along the CV risk continuum
Cardiovascular disease (CVD) remains the leading cause of death worldwide. The risk of a cardiovascular (CV) event is not static and increases along a continuum, making identification and management complex.Aspirin has been the cornerstone of antiplatelet therapy in CV risk reduction and remains the...
I tiakina i:
Ngā kaituhi matua: | Francesca Santilli (Author), Gerhard Albrecht (Author), Michael Blaha (Author), Angel Lanas (Author), Li Li (Author), Dirk Sibbing (Author) |
---|---|
Hōputu: | Pukapuka |
I whakaputaina: |
Elsevier,
2024-06-01T00:00:00Z.
|
Ngā marau: | |
Urunga tuihono: | Connect to this object online. |
Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Ngā tūemi rite
-
Advanced subclinical atherosclerosis: A novel category within the cardiovascular risk continuum with distinct treatment implications
mā: Michael J. Blaha, me ētahi atu.
I whakaputaina: (2023) -
Implications of the heterogeneity between guideline recommendations for the use of low dose aspirin in primary prevention of cardiovascular disease
mā: Xiao-Ying Li, me ētahi atu.
I whakaputaina: (2022) -
Phosphorus Along the Soil-Freshwater-Ocean Continuum
I whakaputaina: (2019) -
Stroke survivors' experiences of team support along their recovery continuum
mā: W. Hartford, me ētahi atu.
I whakaputaina: (2019) -
How Family Physicians Practice the Principle of Remission Along the Glycemic Continuum
mā: Stephanie T. Fulleborn, me ētahi atu.
I whakaputaina: (2020)